Corcept Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Corcept Therapeutics stock have an average target of 99.75, with a low estimate of 76 and a high estimate of 130. The average target predicts an increase of 81.86% from the current stock price of 54.85.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$76	$99.75	$115	$130
Change	+38.56%	+81.86%	+109.66%	+137.01%

Analyst Ratings

The average analyst rating for Corcept Therapeutics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Amsellem Piper Sandler	Piper Sandler	Buy Maintains $67 → $78	Buy	Maintains	$67 → $78	+42.21%	Feb 27, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $115	Strong Buy	Reiterates	$115	+109.66%	Feb 27, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $80 → $115	Strong Buy	Maintains	$80 → $115	+109.66%	Feb 11, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $80	Strong Buy	Reiterates	$80	+45.85%	Feb 7, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $78 → $130	Strong Buy	Maintains	$78 → $130	+137.01%	Jan 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

923.49M

from 675.04M

36.81%

from 675.04M

Revenue Next Year

1.20B

from 923.49M

29.94%

from 923.49M

EPS This Year

2.15

from 1.23

74.77%

from 1.23

EPS Next Year

4.57

from 2.15

112.57%

from 2.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	353.87M	365.98M	401.86M	482.38M	675.04M	923.49M	1.20B	1.54B
Revenue Growth	15.46%	3.42%	9.80%	20.04%	39.94%	36.81%	29.94%	28.33%
EPS	0.85	0.89	0.87	0.94	1.23	2.15	4.57	4.95
EPS Growth	10.39%	4.71%	-2.25%	8.05%	30.85%	74.77%	112.57%	8.26%
Forward PE	-	-	-	-	-	25.52	12.00	11.09
No. Analysts	-	-	-	-	-	6	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	971.0M	1.4B	2.0B
Avg	923.5M	1.2B	1.5B
Low	869.3M	1.0B	1.2B

Revenue Growth

Revenue Growth	2025	2026	2027
High	43.8%	56.4%	65.0%
Avg	36.8%	29.9%	28.3%
Low	28.8%	11.6%	-1.9%

EPS Forecast

EPS	2025	2026	2027
High	2.69	7.01	6.87
Avg	2.15	4.57	4.95
Low	1.33	2.34	3.17

EPS Growth

EPS Growth	2025	2026	2027
High	118.5%	226.3%	50.3%
Avg	74.8%	112.6%	8.3%
Low	8.4%	9.0%	-30.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.